133 related articles for article (PubMed ID: 26390560)
21. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study.
Michalakis K; Williams CJ; Mitsiades N; Blakeman J; Balafouta-Tselenis S; Giannopoulos A; Mantzoros CS
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):308-13. PubMed ID: 17301264
[TBL] [Abstract][Full Text] [Related]
22. Differential up-regulation of erythropoietin and its receptor in benign and malignant prostatic tissue.
Xu C; Zhou T; He M; Sun Y
Urol Oncol; 2010; 28(3):314-9. PubMed ID: 19070519
[TBL] [Abstract][Full Text] [Related]
23. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
[TBL] [Abstract][Full Text] [Related]
24. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer antigen-1 as a potential novel marker for prostate cancer.
Liu BQ; Wu YD; Li PH; Wei JX; Zhang T; Liu RL
Asian J Androl; 2007 Nov; 9(6):821-6. PubMed ID: 17968469
[TBL] [Abstract][Full Text] [Related]
26. [Multiple interactions between the kallikrein-kinin and the renin angiotensin systems].
Yoshida H
Nihon Rinsho; 2005 Mar; 63 Suppl 3():437-41. PubMed ID: 15813107
[No Abstract] [Full Text] [Related]
27. Kinin-related effects of angiotensin-converting enzyme inhibition.
Bönner G
Clin Physiol Biochem; 1990; 8 Suppl 1():6-15. PubMed ID: 2257722
[TBL] [Abstract][Full Text] [Related]
28. [The role of the renin-angiotensin and kallikrein-kinin systems and of a number of hormonal substances in the pathogenesis of the acute period in myocardial infarct].
Dobrin BIu; Kuskov SV
Lik Sprava; 1997; (6):14-7. PubMed ID: 9589915
[No Abstract] [Full Text] [Related]
29. Four decades of ocular renin-angiotensin and kallikrein-kinin systems (1977-2017).
Igić R
Exp Eye Res; 2018 Jan; 166():74-83. PubMed ID: 28549900
[TBL] [Abstract][Full Text] [Related]
30. Local bone interaction between renin-angiotensin system and kallikrein-kinin system in diabetic rat.
Li Y; Shen GS; Yu C; Li GF; Shen JK; Xu YJ; Gong JP
Int J Clin Exp Pathol; 2015; 8(2):1604-12. PubMed ID: 25973045
[TBL] [Abstract][Full Text] [Related]
31. The plasma kallikrein-kinin system counterbalances the renin-angiotensin system.
Schmaier AH
J Clin Invest; 2002 Apr; 109(8):1007-9. PubMed ID: 11956236
[No Abstract] [Full Text] [Related]
32. Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: quantitative expression analysis and evaluation of its clinical significance.
Avgeris M; Stravodimos K; Scorilas A
Prostate; 2011 Dec; 71(16):1780-9. PubMed ID: 21520157
[TBL] [Abstract][Full Text] [Related]
33. ProNGF correlates with Gleason score and is a potential driver of nerve infiltration in prostate cancer.
Pundavela J; Demont Y; Jobling P; Lincz LF; Roselli S; Thorne RF; Bond D; Bradshaw RA; Walker MM; Hondermarck H
Am J Pathol; 2014 Dec; 184(12):3156-62. PubMed ID: 25285721
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer.
Sierra Díaz E; Sánchez Corona J; Rosales Gómez RC; Gutierrez Rubio SA; Vázquez Camacho JG; Solano Moreno H; Morán Moguel MC
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):241-6. PubMed ID: 20026870
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
36. [Kallikrein-kinin in hypertension].
Omata K
Nihon Rinsho; 2004 Mar; 62 Suppl 3():228-33. PubMed ID: 15171374
[No Abstract] [Full Text] [Related]
37. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological and functional characterization of bradykinin B2 receptor in human prostate.
Srinivasan D; Kosaka AH; Daniels DV; Ford AP; Bhattacharya A
Eur J Pharmacol; 2004 Nov; 504(3):155-67. PubMed ID: 15541417
[TBL] [Abstract][Full Text] [Related]
39. Association of Pb, Cd, and Se concentrations and oxidative damage-related markers in different grades of prostate carcinoma.
Guzel S; Kiziler L; Aydemir B; Alici B; Ataus S; Aksu A; Durak H
Biol Trace Elem Res; 2012 Jan; 145(1):23-32. PubMed ID: 21809052
[TBL] [Abstract][Full Text] [Related]
40. Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).
Trojan L; Michel MS; Rensch F; Jackson DG; Alken P; Grobholz R
J Urol; 2004 Jul; 172(1):103-7. PubMed ID: 15201747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
